Regenxbio Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | 19.3 | 32.4 | 32.2 | 16.4 | – | – | – | – | – | – | – | – | – | – | – | 11.3 | 14.1 | 11.7 | 15.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 50.5 | 107.3 | 110.7 | 68.7 | 101.6 | 99.9 | 7.2 | 14.4 | 14.3 | 7.5 | 24.0 | 34.4 | 20.4 | 42.9 | 23.1 | 22.6 | 7.4 | 11.0 | 9.2 | 10.3 | 19.2 | 3.1 | 3.0 | 2.2 | 2.4 | 8.7 | 7.5 | 9.0 | 7.3 | 8.8 | 11.1 | 6.6 | 6.3 | 4.7 | 2.4 | 2.7 | 3.1 | 4.4 | 5.0 | 3.6 | |
| 2.1 | 3.0 | 2.4 | 2.9 | 5.2 | 5.7 | 3.4 | 8.0 | 5.2 | 3.2 | 4.3 | 3.8 | 2.8 | 3.4 | 2.9 | 3.4 | 2.6 | 4.5 | 2.6 | 3.3 | 3.9 | 1.9 | 2.1 | 1.7 | 2.0 | 1.9 | 1.8 | 2.1 | 2.0 | 2.5 | 2.5 | 1.7 | 1.8 | 1.5 | 1.4 | 2.0 | 3.1 | 7.3 | 20.9 | 8.9 | |
| 46.7 | 101.9 | 93.0 | 62.2 | 95.6 | 95.4 | 6.7 | 13.8 | 13.5 | – | 23.4 | 33.4 | 19.2 | 41.0 | 21.8 | 21.1 | 6.8 | 8.8 | 7.3 | 8.7 | 16.7 | 2.3 | 2.6 | 2.0 | 2.1 | 7.9 | 6.9 | 8.3 | 6.8 | 8.5 | 10.4 | 6.4 | 5.7 | 4.1 | 1.6 | 2.3 | 3.1 | 4.5 | 4.9 | 3.5 | |
| – | – | – | – | – | – | 18.3 | 32.9 | 33.5 | – | – | – | – | – | – | – | – | – | – | – | – | 6.2 | 8.2 | 6.7 | 8.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | 92.8 | 28.2 | 30.4 | 17.9 | 544.4 | – | – | – | – | – | – | – | – | – | – | 11.5 | 10.7 | 9.5 | 9.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -9.8% | -11.5% | -13.4% | -11.6% | -7.3% | -6.3% | 1.1% | 3.5% | 3.3% | 5.6% | 0.2% | -4.9% | -7.8% | -7.9% | -10.6% | -9.0% | -12.5% | -4.8% | -8.1% | -8.5% | -8.9% | 8.7% | 9.4% | 10.6% | 10.4% | -24.2% | -31.3% | -27.1% | -31.9% | -28.8% | -20.6% | -32.9% | -34.6% | -44.8% | -23.5% | -21.5% | -21.2% | -17.0% | -53.7% | -39.2% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 79.4% | 79.1% | 79.5% | 79.9% | 75.9% | -52.8% | 87.2% | 88.2% | 88.5% | 95.6% | 91.7% | 90.3% | 88.6% | 76.6% | 77.6% | 76.3% | 79.8% | 76.9% | 76.2% | 73.8% | 58.1% | 89.0% | 86.8% | 86.4% | 86.5% | 51.6% | 60.8% | 59.3% | 61.0% | 54.0% | 47.1% | 42.7% | 39.5% | 49.8% | 76.5% | 79.9% | 50.0% | 52.9% | -0.1% | 54.2% | |
| -686.8% | -1,423.8% | -1,655.8% | -872.5% | -793.7% | -730.2% | 34.5% | 40.1% | 38.4% | 40.3% | -57.3% | -169.7% | -165.3% | -422.9% | -290.0% | -256.7% | -73.1% | -77.1% | -80.6% | -84.3% | -222.5% | 34.0% | 28.0% | 25.2% | 22.6% | -233.2% | -234.9% | -276.5% | -263.6% | -297.1% | -304.1% | -277.0% | -289.1% | -277.5% | -100.4% | -105.7% | -96.0% | -94.6% | -292.3% | -94.1% | |
| -661.8% | -1,372.1% | -1,595.2% | -839.9% | -764.1% | -704.0% | 37.3% | 44.4% | 44.3% | 45.7% | -42.0% | -88.6% | -99.6% | -268.9% | -197.2% | -222.2% | -63.1% | -72.0% | -77.9% | -90.0% | -228.1% | 27.2% | 21.4% | 18.7% | 15.3% | -248.7% | -246.5% | -282.7% | -262.2% | -292.0% | -300.0% | -270.7% | -283.2% | -272.5% | -100.6% | -112.7% | -110.3% | -113.8% | -330.2% | -112.6% | |
| -496.6% | -1,235.7% | -1,479.6% | -798.1% | -737.2% | -626.9% | 7.8% | 51.1% | 47.0% | 41.8% | 4.4% | -169.6% | -158.6% | -339.0% | -245.9% | -203.3% | -92.5% | -52.4% | -74.3% | -87.3% | -171.2% | 26.7% | 28.3% | 23.2% | 24.6% | -211.3% | -234.5% | -243.4% | -232.8% | -253.1% | -229.0% | -218.7% | -219.1% | -210.7% | -55.5% | -58.2% | -65.9% | -74.1% | -269.2% | -143.1% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -26.9% | -38.9% | -34.8% | -35.1% | -39.4% | -40.0% | 17.7% | 24.6% | 16.1% | 19.6% | -7.5% | -9.8% | -13.7% | -21.0% | -24.4% | -33.9% | -22.0% | -29.5% | -21.9% | -28.6% | -46.0% | 16.7% | 14.7% | 14.4% | 13.1% | -54.3% | -58.1% | -67.6% | -71.8% | -84.5% | -66.6% | -69.2% | -79.2% | -87.5% | -57.5% | -82.2% | -110.2% | -188.7% | -1,375.6% | -273.7% | |
| -24.8% | -36.5% | -33.1% | -33.1% | -36.7% | -36.8% | 16.7% | 23.3% | 15.5% | 18.4% | -7.0% | -9.2% | -12.6% | -19.0% | -22.1% | -30.0% | -16.9% | -15.7% | -13.8% | -17.4% | -26.5% | 11.5% | 9.9% | 9.5% | 8.3% | -33.6% | -36.1% | -40.2% | -41.1% | -45.9% | -41.3% | -42.3% | -46.0% | -48.7% | -32.1% | -30.2% | -33.9% | -42.8% | -84.8% | -50.8% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -28 | -25 | -82 | -58 | -60 | -47 | -72 | -107 | -142 | – | -48 | -53 | -77 | -67 | -67 | -91 | -90 | -336 | -290 | -255 | -227 | -343 | -190 | -119 | -115 | -91 | -64 | -62 | -46 | -27 | -67 | -18 | -49 | -50 | -122 | -72 | -8.0 | 13 | -7.4 | -29 | |
| – | – | – | – | – | – | -1.4 | -1.5 | -2.0 | – | – | – | – | – | – | – | – | – | – | – | – | -1.9 | -1.3 | -0.8 | -0.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 92.0% | 93.6% | 95.0% | 94.3% | 93.0% | 92.1% | 94.4% | 94.4% | 95.9% | 93.6% | 93.8% | 93.5% | 92.0% | 90.4% | 90.6% | 88.5% | 76.8% | 53.3% | 63.1% | 60.6% | 57.6% | 68.6% | 67.3% | 66.1% | 63.8% | 61.9% | 62.2% | 59.5% | 57.3% | 54.3% | 62.1% | 61.2% | 58.1% | 55.7% | 55.9% | 36.8% | 30.7% | 22.7% | 6.2% | 18.6% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.5 | 0.4 | 0.1 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.83 | -2.38 | -2.78 | -2.42 | -2.48 | -2.35 | 1.55 | 2.22 | 2.34 | 2.57 | -1.00 | -1.32 | -1.74 | -2.57 | -2.76 | -3.62 | -2.35 | -2.97 | -2.90 | -3.42 | -4.98 | 2.90 | 2.36 | 2.10 | 1.70 | -6.47 | -6.22 | -6.30 | -5.93 | -5.99 | -5.69 | -4.76 | -4.70 | -4.46 | -3.07 | -3.41 | -3.44 | -3.75 | -5.53 | -3.71 | |
| 0.28 | 0.17 | 0.17 | 0.29 | 0.32 | 0.33 | 4.15 | 4.98 | 5.29 | 5.61 | 2.39 | 1.50 | 1.75 | 0.95 | 1.40 | 1.63 | 3.73 | 4.13 | 3.73 | 3.79 | 2.18 | 10.67 | 11.03 | 11.23 | 11.10 | 2.60 | 2.52 | 2.23 | 2.26 | 2.05 | 1.90 | 1.76 | 1.66 | 1.64 | 3.05 | 3.03 | 3.12 | 3.29 | 1.68 | 3.29 | |
| 6.81 | 6.11 | 7.98 | 6.90 | 6.29 | 5.87 | 8.73 | 8.99 | 14.54 | 13.07 | 13.39 | 13.49 | 12.72 | 12.20 | 11.32 | 10.68 | 10.69 | 10.10 | 13.26 | 11.93 | 10.82 | 17.34 | 16.06 | 14.63 | 13.04 | 11.92 | 10.70 | 9.32 | 8.26 | 7.08 | 8.54 | 6.88 | 5.93 | 5.10 | 5.33 | 4.15 | 3.12 | 1.99 | 0.40 | 1.35 | |
| -1.38 | -2.14 | -2.58 | -2.30 | -2.39 | -2.09 | 0.32 | 2.55 | 2.49 | 2.35 | 0.11 | -2.54 | -2.77 | -3.24 | -3.45 | -3.31 | -3.45 | -2.16 | -2.77 | -3.31 | -3.74 | 2.85 | 3.12 | 2.61 | 2.73 | -5.50 | -5.92 | -5.42 | -5.26 | -5.19 | -4.34 | -3.85 | -3.64 | -3.45 | -1.69 | -1.76 | -2.06 | -2.44 | -4.51 | -4.71 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.